Ameliorative effects of ceftriaxone sodium combined with dexamethasone on infantile purulent meningitis and associated effects on brain‑derived neurotrophic factor levels

Zeng,Yiwen; Zhang,Wei

doi:10.3892/etm.2020.8769

Ameliorative effects of ceftriaxone sodium combined with dexamethasone on infantile purulent meningitis and associated effects on brain‑derived neurotrophic factor levels

Authors:
- Yiwen Zeng
- Wei Zhang
View Affiliations

Affiliations: Department of Pediatrics, Yongchuan Hospital of Chongqing Medical University, Yongchuan, Chongqing 402160, P.R. China
Published online on: May 19, 2020 https://doi.org/10.3892/etm.2020.8769
Pages: 945-951
Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to evaluate the role of ceftriaxone sodium combined with dexamethasone on the treatment of infant purulent meningitis (PM) and to measure brain‑derived neurotrophic factor (BDNF) levels in children with PM. Of the 177 patients enrolled into the present study, 92 patients received ceftriaxone sodium+dexamethasone (combination group) and 85 patients received ceftriaxone sodium alone (monotherapy group). The time taken for the body temperature, peripheral blood (PB) and cerebrospinal fluid (CSF) white blood cell (WBC) counts to recover back to normal levels were compared between the two groups. In addition, changes in the CSF WBC counts, CSF protein and sugar concentrations, BDNF levels, effective treatment rates and incidence of adverse reactions three days before treatment (T1), after one week of treatment (T2) and after two weeks of treatment (T3) were compared between the two groups. In the combination group, the recovery time of body temperature, WBC counts in both PB and CSF were significantly lower compared with those in the monotherapy group. The combination group also exhibited lower CSF protein concentrations and higher CSF sugar concentrations at T2 and T3 compared with those in the monotherapy group (P<0.05). The effective treatment rate of the combination group was significantly higher compared with that of the monotherapy group (P=0.006). CSF protein at T1, T2 T3, and CSF sugar concentrations and BDNF levels at T1 were significantly lower in the combination group than in the monotherapy group (P<0.05) while the CSF sugar concentrations at T2, T3 were higher in the combination group than in the monotherapy group (P<0.05). Taken together, these observations suggest that ceftriaxone combined with dexamethasone was superior compared with that of ceftriaxone alone for the treatment of infantile PM, and that this combination therapy may improve the effective treatment rate and accelerate patient rehabilitation.

View Figures

View References

1	Qian Y, Wong CC, Lai SC, Lin ZH, Zheng WL, Zhao H, Pan KH, Chen SJ and Si JM: Klebsiella pneumoniae invasive liver abscess syndrome with purulent meningitis and septic shock: A case from mainland China. World J Gastroenterol. 22(2861)2016.PubMed/NCBI View Article : Google Scholar
2	He Z, Li X and Jiang L: Clinical analysis on 430 cases of infantile purulent meningitis. Springerplus. 5(1994)2016.PubMed/NCBI View Article : Google Scholar
3	Agossou J, Adédémy JD, Noudamadjo A, Houessou MRM, Tsawlassou P, Assogba R, Sagbo GG, Lalya HF, Alao MJ, Bankolé H, et al: Serotypes of bacteria encountered in childhood purulent meningitis in children in Parakou (Benin) in 2011. Open J Pediat. 6(109)2016.
4	Du H, Liu E, Xu C, Zhao S, Xiang H and Li Z: Prognostic value of funisitis and/or chorionic vasculitis compared to histologic chorioamnionitis in full-term infants. The J Matern Fetal Neonatal Med. 30:169–173. 2017.PubMed/NCBI View Article : Google Scholar
5	Liu C and Zhao D: Correlation between CD64 and PCT levels in cerebrospinal fluid and degree of hearing impairment sequelae in neonates with purulent meningitis. Exp Ther Med. 14:5997–6001. 2017.PubMed/NCBI View Article : Google Scholar
6	Lan SY, Lin JJ, Hsia SH, Wang HS, Chiu CH and Lin KL: CHEESE Study Group: Analysis of fulminant cerebral edema in acute pediatric encephalitis. Pediatr Neonatol. 57:402–407. 2016.PubMed/NCBI View Article : Google Scholar
7	Ai J, Xie Z, Liu G, Chen Z, Yang Y, Li Y, Chen J, Zheng G and Shen K: Etiology and prognosis of acute viral encephalitis and meningitis in Chinese children: A multicentre prospective study. BMC Infect Dis. 17(494)2017.PubMed/NCBI View Article : Google Scholar
8	Yimer EM, Hishe HZ and Tuem KB: Repurposing of the β-lactam antibiotic, ceftriaxone for neurological disorders: A review. Front Neurosci. 13(236)2019.PubMed/NCBI View Article : Google Scholar
9	Xu W, Yin M, Huo MC, Yan JL, Yang Y and Liu CF: Changes in blood CD4⁺ CD25⁺ regulatory T cells in children with severe purulent meningitis. Zhongguo Dang Dai Er Ke Za Zhi. 18:821–825. 2016.(In Chinese). PubMed/NCBI
10	Rahman M, Khan MA, Abdul Rub M, Hoque MA and Asiri AM: Investigation of the effect of various additives on the clouding behavior and thermodynamics of polyoxyethylene (20) sorbitan monooleate in absence and presence of ceftriaxone sodium trihydrate drug. J Chem Eng Data. 62:1464–1474. 2017.
11	Rahman M, Khan MA, Rub MA and Hoque MA: Effect of temperature and salts on the interaction of cetyltrimethylammonium bromide with ceftriaxone sodium trihydrate drug. J Mol Liquids. 223:716–724. 2016.
12	Patel N, Lalwani D, Gollmer S, Injeti E, Sari Y and Nesamony J: Development and evaluation of a calcium alginate based oral ceftriaxone sodium formulation. Prog Biomater. 5:117–133. 2016.PubMed/NCBI View Article : Google Scholar
13	Guo X, Wan J, Yu X and Lin Y: Study on preparation of SnO₂-TiO₂/Nano-graphite composite anode and electro-catalytic degradation of ceftriaxone sodium. Chemosphere. 164:421–429. 2016.PubMed/NCBI View Article : Google Scholar
14	Fu Y, Jing J, Ren T and Zhao H: Intratympanic dexamethasone for managing pregnant women with sudden hearing loss. J Int Med Res. 47:377–382. 2019.PubMed/NCBI View Article : Google Scholar
15	Dileep A, Khan NB and Sheikh SS: Comparing neonatal respiratory morbidity in neonates delivered at term by elective Caesarean section with and without dexamethasone: Retrospective cohort study. J Pak Med Assoc. 65:607–611. 2015.PubMed/NCBI
16	Tange M, Yoshida M, Nakai Y and Uchida T: The role of an impurity in ceftriaxone sodium preparation for injection in determining compatibility with calcium-containing solutions. Chem Pharm Bull (Tokyo). 64:207–214. 2016.PubMed/NCBI View Article : Google Scholar
17	Di Cicco M, Bellino EM, Marabotti A, Luti L, Peroni DG and Baroncelli GI: Acute dacryocystitis with giant lacrimal abscess: A case report. Ital J Pediatr. 46(15)2020.PubMed/NCBI View Article : Google Scholar
18	Guo LY, Zhang ZX, Wang X, Zhang PP, Shi W, Yao KH, Liu LL, Liu G and Yang YH: Clinical and pathogenic analysis of 507 children with bacterial meningitis in Beijing, 2010-2014. Int J Infect Dis. 50:38–43. 2016.PubMed/NCBI View Article : Google Scholar
19	Rodriguez WJ, Ross S, Khan WN and Goldenberg R: Clinical and laboratory evaluation of cefamandole in infants and children. J Infect Dis. 137:S150–S154. 1978.PubMed/NCBI View Article : Google Scholar
20	Ekhtiyari E, Barzegar M, Mehdizadeh A, Shaaker M, Ghodoosifar S, Abhari A and Darabi M: Differential fatty acid analysis of cerebrospinal fluid in infants and young children with suspected meningitis. Child's Nerv Sys. 33:111–117. 2017.PubMed/NCBI View Article : Google Scholar
21	Kępa L, Oczko-Grzesik B, Stolarz W and Boroń-Kaczmarska A: Cerebrospinal fluid ferritin concentration in patients with purulent, bacterial meningitis-own observations. Przegl Epidemiol. 70:593–603. 2016.(In English, Polish). PubMed/NCBI
22	Sharma VD, Singla A, Chaudhary M and Taneja M: Population pharmacokinetics of fixed dose combination of ceftriaxone and sulbactam in healthy and infected subjects. AAPS PharmSciTech. 17:1192–1203. 2016.PubMed/NCBI View Article : Google Scholar
23	Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, et al: Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): A randomised, phase 3, open-label, multicentre study. Lancet Oncol. 17:27–38. 2016.PubMed/NCBI View Article : Google Scholar
24	Jha A, Dwivedi NC, Verma SK and Chaurasia AK: Role of cerebrospinal fluid, creatine kinase and lactate dehydrogenase enzyme levels in diagnostic and prognostic evaluation of tubercular and pyogenic meningitis. Int J Adv Med. 4:824–829. 2017.
25	Scoppetta TLPD, da Rocha AJ and Nunes RH: Meningitis, empyema, and brain abscess in adults. In: Editors. Critical Findings in Neuroradiology. Springer. 141–154. 2016.
26	Ahmed R: Gestational dexamethasone alters fetal neuroendocrine axis. Toxicol Lett. 258:46–54. 2016.PubMed/NCBI View Article : Google Scholar
27	Panackal AA, Chittboina P, Marr KA, Bielekova B and Williamson PR: Dexamethasone in cryptococcal meningitis. N Engl J Med. 375(188)2016.PubMed/NCBI View Article : Google Scholar
28	Miao YL, He P, Zhang WX, Zhang WZ, Feng M and Ni Y: Anti-inflammatory mechanism of Crepis crocea based on NF-κB signaling pathway and ~1H-NMR metabonomics. Zhongguo Zhong Yao Za Zhi. 45:946–954. 2020.(In Chinese). PubMed/NCBI View Article : Google Scholar
29	Barna L, Walter FR, Harazin A, Bocsik A, Kincses A, Tubak V, Jósvay K, Zvara Á, Campos-Bedolla P and Deli MA: Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage. Fluids Barriers. 17(5)2020.PubMed/NCBI View Article : Google Scholar
30	Zhang JC, Yao W and Hashimoto K: Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Curr Neuropharmacol. 14:721–731. 2016.PubMed/NCBI View Article : Google Scholar
31	El Morsy EM and Mae A: Protective effects of lycopene on hippocampal neurotoxicity and memory impairment induced by bisphenol A in rats. Hum Exp Toxicol. 960327120909882:2020.PubMed/NCBI View Article : Google Scholar